S-1
S-1
- Company
- VYNE Therapeutics Inc.
- Filed
- December 28, 2017
- Accession Number
- 0001628280-17-012730
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →